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Abstract
Background: Using an indirect immunoperoxidase technique, we have studied the distribution of
immunoreactive fibers and cell bodies containing neurokinin in the adult human brainstem with no
prior history of neurological or psychiatric disease.
Results: Clusters of immunoreactive cell bodies and high densities of neurokinin-immunoreactive
fibers were located in the periaqueductal gray, the dorsal motor nucleus of the vagus and in the
reticular formation of the medulla, pons and mesencephalon. Moreover, immunoreactive cell
bodies were found in the inferior colliculus, the raphe obscurus, the nucleus prepositus hypoglossi,
and in the midline of the anterior medulla oblongata. In general, immunoreactive fibers containing
neurokinin were observed throughout the whole brainstem. In addition to the nuclei mentioned
above, the highest densities of such immunoreactive fibers were located in the spinal trigeminal
nucleus, the lateral reticular nucleus, the nucleus of the solitary tract, the superior colliculus, the
substantia nigra, the nucleus ambiguus, the gracile nucleus, the cuneate nucleus, the motor
hypoglossal nucleus, the medial and superior vestibular nuclei, the nucleus prepositus hypoglossi
and the interpeduncular nucleus.
Conclusion: The widespread distribution of immunoreactive structures containing neurokinin in
the human brainstem indicates that neurokinin might be involved in several physiological
mechanisms, acting as a neurotransmitter and/or neuromodulator.
Background
The mammalian tachykinin peptides include neurokinin
A (NKA), neurokinin B (NKB) and substance P (SP) [1]. It
is known that these three neuropeptides have a common
C-terminal amino acid sequence and that NKA and SP are
derived from the preprotachykinin A gene, whereas NKB
is derived from the preprotachykinin B gene. It is also
known that the biological actions of NKA, NKB and SP are
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mediated by three receptors, named neurokinin (NK)-1,
NK-2 and NK-3 [2]. Thus, the tachykinins have been im-
plicated in several physiological actions such as salivation,
the regulation of smooth muscle contraction, depolariza-
tion of central neurons, hyperactivity, interaction with
dopaminergic A-10 neurons mediating behavioral activa-
tion, regulation of blood pressure, and the transmission
of the baroreceptor reflex [3–7]. In addition, a loss of tach-
ykinin-containing neurons has been described in neuro-
degenerative diseases [8], suggesting that the decrease in
the amount of tachykinins could be involved in these and
other diseases [9,10].
Several inmunocytochemical, " in situ " hybridization and
radioimmunoassay studies have demonstrated the distri-
bution of tachykinins in the rat, the cat and the monkey
CNS [11–20]. In the human brainstem, the presence of SP
has been widely studied [21–27]. Moreover, in humans,
the neurokinin B system has been studied in the cerebral
cortex, hippocampus and the hypothalamus [28]. Howev-
er, no data are available in the literature concerning the
distribution of neurokinin-immunoreactive structures in
the human brainstem. Thus, in the present work we at-
tempted to study in detail the distribution of fibers and
cell bodies containing neurokinin in the human brain-
stem, using an immunoperoxidase technique, and to
compare our findings with the distribution of other tach-
ykinins previously described in the human brainstem
[23–25,27]. Finally, we report here a widespread distribu-
tion of fibers and cell bodies containing neurokinin in the
human brainstem.
Results
As shown in Figures 1, 2, 3, neurokinin-like immunoreac-
tive (NK-ir) structures are widely distributed throughout
the human brainstem. In general, the distribution of the
immunoreactive structures (fibers and cell bodies), as well
as the density of such structures, were quite similar in the
four brainstems studied. In the three brainstem regions
(medulla oblongata, pons and mesencephalon), the high-
est density of immunoreactive structures was generally ob-
served in their dorsal parts. In addition, the clusters of cell
bodies containing NK were almost always observed in the
dorsal part of the human brainstem. Finally, in general,
the NK-ir cell bodies observed in the human brainstem
were large (showing the longest diameter between 20–55
µm).
Distribution of NK-ir structures in the human medulla 
oblongata
NK-ir cell bodies
A low density of immunoreactive cell bodies containing
NK was observed caudally in the medullary central gray
(Figs. 1A; 4A), whereas more rostrally (Fig. 1B) such clus-
ters of NK-ir perikarya showed a moderate density. At the
Figure 1
Distribution of NK-ir fibers and cell bodies in frontal planes 
of the human brainstem from the caudal (Fig. 1A) to the 
anterior (Fig. 3C) levels. Cell bodies containing neurokinin 
are represented by closed circles, whereas immunoreactive 
fibers are represented by dotted lines (single fibers or low 
density), continuous lines (moderate density) and crossed 
lines (high density). See list of abbreviations for 
nomenclature.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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Figure 2
Distribution of NK-ir fibers and cell bodies in frontal planes 
of the human brainstem from the caudal (Fig. 1A) to the 
anterior (Fig. 3C) levels. Cell bodies containing neurokinin 
are represented by closed circles, whereas immunoreactive 
fibers are represented by dotted lines (single fibers or low 
density), continuous lines (moderate density) and crossed 
lines (high density). See list of abbreviations for 
nomenclature.
Figure 3
Distribution of NK-ir fibers and cell bodies in frontal planes 
of the human brainstem from the caudal (Fig. 1A) to the 
anterior (Fig. 3C) levels. Cell bodies containing neurokinin 
are represented by closed circles, whereas immunoreactive 
fibers are represented by dotted lines (single fibers or low 
density), continuous lines (moderate density) and crossed 
lines (high density). See list of abbreviations for 
nomenclature.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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latter level (Fig. 1B), a moderate density was also observed
in the dorsal motor nucleus of the vagus and a low density
below the nucleus of the solitary tract. More rostrally (Fig.
1C) three populations of immunoreactive cell bodies
were observed: the first located along the midline (high
density); the second in the dorsal motor nucleus of the
vagus (high density)(Fig. 5A,5B); and the third in the re-
ticular formation (nucleus reticularis gigantocellularis in-
cluded)(moderate density), above the dorsal accessory
olivary nucleus and the central tegmental tract (Fig.
6A,6B). In addition, a moderate density of immunoreac-
tive cell bodies containing NK was observed in the raphe
obscurus (not shown in Figures).
NK-ir fibers
A high density of immunoreactive fibers containing NK
was observed in the following regions: in the caudaldorsal
part of the cuneate nucleus (Fig. 1A), the medullary cen-
tral gray (Figs. 1A,1B; 4A), the dorsal motor nucleus of the
vagus (Figs. 1A,1B; 5A,5B), the nucleus of the solitary tract
(Figs. 1B,1C; 5A), the raphe obscurus, the spinal trigemi-
nal nucleus (gelatinosa part) (Figs. 1A,1B,1C; 7B), the in-
ferior salivatory nucleus, the anterolateral system (Fig.
1A,1B,1C), the nucleus of the accessory nerve (Fig. 1A),
the lateral part of the reticular formation (Figs. 1B,1C;
7A), the nucleus ambiguus (Fig. 1B,1C), the lateral reticu-
lar nucleus (Fig. 1B,1C), and the dorsal accessory olivary
nucleus (Figs. 1C; 6B). A moderate density was found in
the gracile nucleus (Fig. 1A,1B), the caudal-ventral part of
the cuneate nucleus (Fig. 1A), as well as in the whole nu-
cleus (Fig. 1B), the caudal end of the motor hypoglossal
nucleus (Fig. 1A), the rubrospinal tract (Fig. 1A,1B,1C),
the medial C1 cells (Fig. 1A), the spinal trigeminal tract
(Fig. 1B,1C), the medial part of the reticular formation
(nucleus reticularis gigantocellularis included) (Fig.
1B,1C), the motor hypoglossal nucleus (Fig. 1B,1C), the
medial accessory olivary nucleus (Fig. 1B), the medial ves-
tibular nucleus (Fig. 1C) and in the spinal (inferior) ves-
tibular nucleus (Fig. 1C).
A low density of immunoreactive fibers containing NK
was found in the fasciculus gracilis (Fig. 1A), the
Figure 4
A. Immunoreactive cell bodies (arrows) and fibers (arrow-
heads) containing NK in the medullary central gray (CeGy). 
D: dorsal; V: ventricle. Scale bar: 100 µm
Figure 5
A. Cell bodies (arrows) and fibers (arrowheads) in the dorsal 
motor nucleus of the vagus (DMNu). Note NK-ir fibers 
(arrowheads) in both nucleus of the solitary tract (SolNu) 
and in the solitary tract (SolTr). In addition, NK-ir fibers can 
be observed around the nucleus of the solitary tract. D: dor-
sal; M: medial. Scale bar: 100 µm B. High-power image of the 
area delimited in Figure 5A. D: dorsal; M: medial. Scale bar: 
100 µmBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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fasciculus cuneatus (Fig. 1A,1B), the spinal trigeminal
tract (Fig. 1A), the reticulospinal tract (Fig. 1A,1B,1C), the
dorsal spinocerebellar tract (Fig. 1A), the vestibulospinal
tract (Fig. 1A,1B), the spinal trigeminal nucleus (magno-
cellular part) (Figs. 1A; 7B), the pyramidal tract (Fig.
1A,1B,1C), the lateral cuneate nucleus (Fig. 1B,1C), the
restiform body (Fig. 1B,1C), the medial lemniscus (Fig.
1B,1C), the principal part of the inferior olivary nucleus
(Fig. 1B,1C), and in the midline (Fig. 1C), whereas single
immunoreactive fibers were observed in the ventral
spinocerebellar tract (Fig. 1A,1B,1C), the medial longitu-
dinal fascicle (Fig. 1A,1B,1C), the glossopharyngeal nerve,
the tectospinal tract (Fig. 1A,1B,1C), the central tegmental
tract(Fig. 1B,1C), the dorsal part of the medial longitudi-
nal fascicle(Fig. 1B,1C), the medial accessory olivary nu-
cleus (Fig. 1C), the solitary tract (Figs. 1C; 5A), and in the
glossopharyngeal fibers that join the spinal trigeminal
tract.
Distribution of NK-ir structures in the human pons
NK-ir cell bodies
We observed a moderate density of immunoreactive cell
bodies in the caudal (Fig. 2A) and in the rostral (close to
the central tegmental tract)(Fig. 2C) reticular formation,
Figure 6
A. Cluster of immunoreactive perikarya located laterally in 
the bulbar reticular formation (RetF), between the central 
tegmental tract (CTT) and the lateral reticular nucleus (not 
shown). D: dorsal; M: medial. Scale bar: 100 µm B. Cell bod-
ies (arrows) and fibers (arrowheads) containing NK in the 
bulbar reticular formation (RetF). Note immunoreactive fib-
ers (arrowheads) in the dorsal accessory olivary nucleus 
(DAO). D: dorsal; M: medial. Scale bar: 100 µm
Figure 7
A. Immunoreactive fibers (arrowheads)containing NK in the 
pontine reticular formation (RetF). D: dorsal; M: medial. 
Scale bar: 100 µm B. A high density of immunoreactive fibers 
(arrowheads)in the gelatinosa (g) part of the spinal trigeminal 
nucleus (SpTNu) and a low density in the magnocellular part 
(m) of the same nucleus. D: dorsal; M: medial. Scale bar: 100 
µmBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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between the superior cerebellar peduncle and the antero-
lateral system, as well as in the tegmental central gray (Fig.
2C). In the nucleus prepositus hypoglossi (Fig. 2A), a low
density of immunoreactive cell bodies was found.
NK-ir fibers
In the lateral part (Fig. 2A,2B) and in the medial-most
area (Fig. 2C) of the reticular formation, the nucleus of the
solitary tract (Fig. 2A), the superior salivatory nucleus
(Fig. 2A), and in the tegmental central gray (Fig. 2B,2C) a
high density of NK-ir fibers was visualized. A moderate
density was observed in the following regions: the rubro-
spinal tract (Fig. 2A,2B), the anterolateral system (Fig.
2A,2B,2C), the medial part of the reticular formation (Fig.
2A,2B), the medial parabrachial nucleus (close to the su-
perior cerebellar peduncle)(Fig. 2B), the spinal trigeminal
nucleus (Fig. 2A), the superior vestibular nucleus, the nu-
cleus prepositus hypoglossi (Fig. 2A), and the nuclei of
the lateral lemniscus (Fig. 2B,2C), whereas a low density
of immunoreactive fibers containing NK was found in the
spinal trigeminal tract(Fig. 2A), the restiform body (Fig.
2A), the medial lemniscus (Fig. 2A,2B,2C), the central teg-
mental tract (Fig. 2A,2B,2C), the lateral and medial vestib-
ular nuclei (Fig. 2A), the motor facial nucleus (Fig. 2A),
the superior olive (Fig. 2A,2B), the corticospinal fibers
(Fig. 2A,2B,2C), the pontine nuclei (Fig. 2A,2B,2C), the
abducens nucleus (Fig. 2A), the principal trigeminal nu-
cleus (Fig. 2B), the caudal end of the chief sensory nucleus
(Fig. 2B), the superior cerebellar peduncle (Fig. 2A,2B,2C)
and in the middle cerebellar peduncle (Fig. 2C), Finally,
single immunoreactive fibers were visualized in the
ventral spinocerebellar tract (Fig. 2A,2B), the medial lon-
gitudinal fascicle (Fig. 2A,2B,2C), the tectospinal tract
(Fig. 2A,2B,2C), the dorsal part of the medial longitudinal
fascicle (Fig. 2A,2B), the solitary tract(Fig. 2A), the inter-
nal genu of the facial nerve (Fig. 2A), the facial nerve (Fig.
2A), the trapezoid body (Fig. 2A), the trapezoid nucle-
us(Fig. 2A), the pontocerebellar fibers (Fig. 2A,2B,2C), the
ventral trigeminothalamic tract(Fig. 2A,2B,2C), the juxtar-
estiform body (Fig. 2A), and the trigeminal nerve (Fig.
2C).
Distribution of NK-ir structures in the human 
mesencephalon
NK-ir cell bodies
In the mesencephalon two populations of cell bodies con-
taining NK were observed. The first (high density) was lo-
cated above the periaqueductal gray and the central
nucleus of the inferior colliculus and extended into the
latter nucleus (Figs. 3A; 8A,8B; 9A,9B). The second was
observed in the periaqueductal gray (high density) (Figs.
3B; 10A) and in the reticular formation (low density) (Fig.
3B). In the caudal and rostral regions of the periaqueduc-
tal gray a low density of NK-ir perikarya was found in the
ventromedial part of the nucleus (Fig. 3A,3C).
NK-ir fibers
A high density of NK-ir fibers was found above the periaq-
ueductal gray and the central nucleus of the inferior collic-
ulus (Fig. 3A), the reticular formation (Fig. 3A,3B,3C), the
periaqueductal gray (Figs. 3A,3B,3C; 10A), the lateral
zone of the inferior colliculus (Fig. 3A), the lateral lemnis-
cus(Fig. 3A), the dorsal trigeminothalamic tract (Fig.
3A,3B,3C), the superior colliculus (layers 2–6)(Figs.
3B,3C; 10B), the substantia nigra(Fig. 3B,3C), and in the
pallidonigral, nigrostriatal and corticonigral fibers (Fig.
3B,3C); a moderate density in the spinotectal tract (Fig.
3A,3B,3C), the spinothalamic tract (Fig. 3A,3B,3C), the
ventral trigeminothalamic tract(Fig. 3A,3B,3C), the
Figure 8
A. Low-magnification image of the periaqueductal gray (PAG) 
and the central nucleus of the inferior colliculus (IC, CNu) 
areas. D: dorsal; M: medial. Scale bar: 100 µm B. High magni-
fication of the region delimited in the central rectangle in Fig-
ure 8A. Note the immunoreactive cell bodies and fibers 
(arrowheads). D: dorsal; M: medial. Scale bar: 100 µmBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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superior cerebellar peduncle (Fig. 3A), the dorsal part of
the pontine nuclei (Fig. 3B), the interpeduncular nucle-
us(Fig. 3B,3C), and the rubrospinal tract (Fig. 3C).
In the central nucleus of the inferior colliculus (Figs. 3A;
8B; 9A,9B), the medial lemniscus (Fig. 3A,3B,3C), the
central tegmental tract (Fig. 3A,3B,3C), the corticospinal
fibers (Fig. 3A), the pontine nuclei (Fig. 3A), the crus cer-
ebri(Fig. 3A,3B,3C), the red nucleus (Fig. 3C), the superi-
or colliculus (layer l)(Figs. 3B; 10B), the superior
cerebellar peduncle (Fig. 3C) a low density of NK-ir fibers
was found, whereas single fibers were observed in the
medial longitudinal fascicle (Fig. 3A,3B,3C), the tectospi-
nal tract (Fig. 3A,3B), the pontocerebellar fibers (Fig. 3A),
the trochlear nerve (Fig. 3B), the oculomotor nucleus(Fig.
3C), the dorsal and ventral tegmental decussations (Fig.
3C), and in the oculomotor nerve(Fig. 3C).
Discussion
This is the first detailed study showing the distribution of
NK-ir fibers and cell bodies in the human brainstem with-
out neurological disease. We have to indicate that the in-
tensity and distribution of the immunoreactivity
described in our study were found in elderly persons (over
age 80). Thus, both intensity and distribution may differ
Figure 9
A. High-power image of the region delimited in the left rec-
tangle of Figure 8A. Arrowheads indicate immunoreactive 
fibers. D: dorsal; IC, CNu: central nucleus of the inferior col-
liculus; M: medial. Scale bar: 100 µm B. High magnification of 
the region delimited in the right rectangle of Figure 8A. D: 
dorsal; IC, CNu: central nucleus of the inferior colliculus; M: 
medial. Scale bar: 100 µm
Figure 10
A. NK-ir perikarya (arrows) and fibers (arrowheads) in the 
periaqueductal gray (PAG). D: dorsal; M: medial. Scale bar: 
100 µm B. A low density of immunoreactive fibers is 
observed in layer 1 of the superior colliculus (SC), whereas a 
high density is located in layer 2. D: dorsal; M: medial. Scale 
bar: 100 µmBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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from those observed in other adults. In the medulla
oblongata, the pons, and in the mesencephalon, NK-ir
structures were observed in almost all the nuclei and tracts
of the three brainstem regions studied.
Our results indicate that NK still can be demonstrate 48 h
after death. Moreover, in general, we did not find differ-
ences in the human brainstems, which were perfused " ex
situ " from 24 h to 48 h after death, nor in the density of
the immunoreactivity nor in the distribution of the im-
munoreactive structures. Moreover, no sex differences
were found in the distribution of NK-ir structures in the
human brainstem.
Distribution of NK in the mammalian brainstem
In a previous study, we described the distribution of NK-
ir structures in the cat brainstem [15]. Although the pres-
ence of NK-ir fibers is widely distributed in both cat and
human brainstems, it seems that the distribution is a little
more widespread in humans than in cats. Thus, for exam-
ple, in the former, we found NK-ir fibers in the superior
colliculus, the restiform body, the pyramidal tract, and in
the pontine nuclei, in which in the cat no immunoreactive
fibers were found [15]. Comparing the distribution of cell
bodies containing NK in both cat and human brainstems,
it seems that the distribution is widespread in the feline
(see [15]). In both species NK-ir perikarya were found in
the periaqueductal gray and in the inferior colliculus.
However, in the cat cell bodies containing NK were ob-
served in the superior colliculus, the interpeduncular
nucleus, the lateral reticular nucleus, and in the nucleus of
the solitary tract, as well as in other brainstem localiza-
tions, in which we did not observe NK-ir cell bodies in the
same brainstem regions of humans. By contrast, in hu-
mans, we found NK-ir perikarya located in the dorsal mo-
tor nucleus of the vagus, in which in the cat no
immunoreactive cell bodies were found [15]. The
differences observed in both species concerning the distri-
bution of cell bodies containing NK could be due to tech-
nical considerations, since in the cat colchicine was
administered in the fourth ventricle in order to accumu-
late the peptide in cell bodies [15].
Our data are in agreement with previous results described
in the rat brainstem, using radioimmunoassay techniques
[29,30]. Thus, these latter authors found higher levels of
NKA and lower levels of NKB in both the midbrain and
the medulla oblongata of the rat [30]. In both regions of
the human brainstem, we observed a high density of NK-
ir structures. Moreover, in the midbrain of the rat those
authors described NKA in the substantia nigra, the
interpeduncular nucleus and the periaqueductal gray [29],
just as we found NK-ir structures in these nuclei of the hu-
man brainstem when using immunocytochemical
techniques.
Several studies have shown the distribution of NKA (pre-
protachykinin A mRNA) [12] and NKB (peptide-2; pre-
protachykinin B mRNA)[14,16,17,20] in the CNS of the
rat. The work of Harlan et al. [12] revealed a more
widespread distribution of neurons encoding SP and NKA
preprotachykinin mRNA in the rat brainstem than the dis-
tribution of NK-ir cell bodies observed in the human
brainstem. In addition, taking together the results of the
other four works [14,16,17,20], it also seems that neurons
expressing NKB are more widely distributed in the rat
brainstem than those observed containing NK in the hu-
man brainstem. However, in the rat, those authors did not
find either NKA nor NKB in the dorsal motor nucleus of
the vagus and in the nucleus prepositus hypoglossi, in
which, in humans, we observed NK-ir structures. Future
works must address the issue of whether the discrepancies
observed in the distribution of neurokinin in both species
are due to technical and/or species differences.
Distribution of tachykinins in the human brainstem
In comparison with previous works in which the distribu-
tion of SP was described in the human brainstem [24–27],
it seems that in general, taking together the results
obtained from the four above-mentioned works, the
distribution of NK-ir structures in this region of the hu-
man CNS is quite similar. Thus, for example, SP and NK-
ir structures have been observed in the same human brain-
stem areas such as the periaqueductal gray, substantia ni-
gra, parabrachial nucleus, inferior and superior colliculi,
reticular formation, nucleus of the solitary tract, red nucle-
us, interpeduncular nucleus, medial vestibular nucleus,
cuneate nucleus, spinal trigeminal nucleus, and the dorsal
motor nucleus of the vagus. However, for example, we
found NK-ir structures (the antibody used in this study
principally recognizes NKA)(see specificity of the
antiserum in Methods) in the human brainstem in the lat-
eral cuneate nucleus and in the pyramidal tract, in which
no SP-ir structure has been described in humans [24–27].
It is known that both neuropeptides, SP and NKA, are de-
rived from the same precursor. Thus, the differences
found in the distribution of both neuroactive substances
in the human brainstem could be due to the
intraneuronal segregation transport of the peptides and/
or the different processing of the precursor [see [31]]. An-
other possibility could be that the immunoreactivity ob-
served in those nuclei of the human brainstem in which
NK-ir structures, but not SP, are found is due to NKB (the
antibody used here also recognizes NKB). As is known,
this latter tachykinin derives from the pre-protachykinin B
gene, whereas SP and NKA derive from another precursor,
the pre-protachykinin A gene. Finally, SP-immunoreactive
cell bodies have been found in the human brainstem; for
example, in the superior colliculus and in the spinal
trigeminal nucleus [22,32], in which we did not find NK-
ir perikarya.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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Possible physiological actions of the NK in the human 
brainstem
The widespread distribution of NK-ir structures in the hu-
man brainstem suggests that the peptide might be in-
volved in several physiological actions, acting as a
neurotransmitter and/or neuromodulator. Thus, for ex-
ample, the presence of NK in the nucleus of the solitary
tract, the dorsal motor nucleus of the vagus, the periaque-
ductal gray, the spinal trigeminal nucleus, the interpedun-
cular nucleus, the substantia nigra, the parabrachial
nucleus, and the superior and inferior colliculi indicates
that NK could be involved in a broad range of physiolog-
ical functions such as in cardiovascular, anti-nociceptive,
nociceptive, motor, respiratory, visual and auditory mech-
anisms. Moreover, a possible interaction between NK and
other neuropeptides (e.g., neurotensin and somatostatin)
in the human brainstem could be suggested, since in
almost all the nuclei, located in the dorsal brainstem of
humans, immunoreactive fibers containing NK,
neurotensin and somatostatin have been observed
[33,34]. This observation is in agreement with the results
found in the cat brainstem, in which a clear anatomical re-
lationship between the three above-mentioned neuropep-
tides has been indicated [15]. Finally, we hope that our
study will serve to compare the distribution of NK-ir struc-
tures found in normal human brainstems with those ob-
served, in the future, in brainstems showing a given
pathology (e.g., Parkinson or Alzheimer disease); since,
for example, the loss of SP-containing neurons has been
described in the brainstem of people with Parkinson's dis-
ease [8].
Conclusions
1. There is a widespread distribution of immunoreactive
structures containing neurokinin in the human
brainstem.
2. The highest density of fibers and cell bodies containing
neurokinin was generally observed in the dorsal part of
the human brainstem.
3. The widespread distribution of neurokinin-immunore-
active fibers and cell bodies indicates that neurokinin
might be involved in several physiological functions, act-
ing as a neurotransmitter and/or neuromodulator.
Methods
Brainstem material was obtained from four adult human
brains with no previous history of neurological or
psychiatric disease (two men, 81 and 82 years; two wom-
en, 84 and 87 years), who died from renal failure, anae-
mia, or myocardial infarct. The experimental design,
protocols, and procedures of this work have been per-
formed under the guidelines of the Ethics and Legal rec-
ommendations of the Spanish and European laws. In
addition, this work has been approved by the research
commission of the University of Málaga (Spain). Autop-
sies were carried out within 24–48 h after death. The
brains were removed and perfused " ex situ " via the carot-
id and vertebral arteries. Both arteries were connected to a
pressure-driven pump and the brains were perfused at
normal mean arterial pressure with 1000 ml of phos-
phate-buffered saline (PBS) 0.15 M (pH 7.2) followed by
3000 ml of 4% paraformaldehyde in the same buffer. Af-
ter postfixation (30 days in the latter fixative solu-
tion)(4°C), the brains were keept in PBS at 4°C and
cryoprotected, at the same temperature, by immersion in
increasing sucrose baths (10–30%) until they sank. The
brainstems were dissected out and, using a cryostat, 60
µm-thick frontal sections of the mesencephalon, pons
and medulla oblongata were cut, collected in PBS, kept at
4°C and processed for immunostaining. In general, six of
seven sections were used for immunocytochemistry, and
the remaining section was stained for Nissl.
Immunocytochemistry
In order to avoid possible interference by endogenous
peroxidase, free-floating sections were treated with
distilled water containing NH3 (20%), H2O2 (30%) and
NaOH (1%) for 20 min [35]. Then, the sections were
washed for 20 min in PBS and preincubated for 30 min in
PBS containing 1% normal horse serum and 0.3% Triton
X-100. The sections were then washed for 30 min in the
last solution containing caseine (0.5%) and were incubat-
ed overnight at 4°C in PBS containing Triton X-100
(0.3%) and normal horse serum (1%), as well as anti-neu-
rokinin antiserum, and diluted 1/15000 – 1/30000. The
sections were then washed in PBS (30 min) and incubated
for 60 min at room temperature with biotinylated antirab-
bit immunogamma globulin diluted 1/200 in PBS. After a
30 min wash with PBS, the sections were incubated for 1
h with avidin-biotin-peroxidase complex (Vectastain)
(diluted 1/100). Finally, after washing the sections in PBS
(30 min) and Tris-HCl buffer (pH 7.6)(10 min), the tis-
sue-bound peroxidase was developed by H2O2 using 3, 3'
diaminobenzidine as chromogen. The sections were
rinsed with PBS and coverslipped with PBS/Glycerol (1/
1).
Specificity of the antiserum
Polyclonal anti-neurokinin antibody was raised in rabbits
against immunogens prepared by coupling the synthetic
NKA peptide (Bachem, Switzerland) to a carrier protein
(human serum albumin) with glutaraldehyde. The specif-
icity of the immunostaining was controlled by omission
of the neurokinin antibody in the first incubation bath.
No immunoreactivity was found. Moreover, control
sections were incubated in the primary antiserum previ-
ously absorbed by neurokinin A or neurokinin B. Inhibi-
tion of staining was obtained after preincubation of theBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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first antiserum with neurokinin A (10-4 and 10-5 M) or
with neurokinin B (10-3 M). Moreover, no significant re-
duction in immunoreactivity was observed on incubating
the first antiserum with an excess of SP, eledoisin or kassi-
nin. Thus, the antibody used, in the present work, princi-
pally recognizes NKA but shows some cross-reactivity
with NKB. For this reason, the term " neurokinin-like im-
munoreactive " (NK-ir) is used to described the staining
results in our material. However, we have to indicate that
the immunoreactivity found in this study is mainly due to
NKA (see and compare Figs. 6B; 10A; 11A,11B), since the
distribution of NKB is much less widespread in the hu-
man brainstem, in comparison with the distribution
found for NKA(personal observation obtained after using
a very specific rabbit anti-NKB antibody from Peninsula).
Thus, the anti-NKB antibody (IHC 7357) showed the fol-
lowing crossreactivities: 100% for NKB, 2% for physalae-
min, 1% for eledoisin, 0.6% for kassinin, 0.2% for
substance P, 0.1% for NKA and 0% for neuropeptide K.
Moreover, in the nuclei of the human brainstem in which
NKB was observed, the density of the immunoreactivity
for NKB was lesser than that found in the same nuclei for
NKA (see and compare Figs. 6B; 10A; 11A,11B).
Mapping
Mapping was carried out according to the atlas of the hu-
man brain of Haines [36], and the same atlas was used for
the terminology of the brainstem nuclei. In addition, the
atlas of Paxinos et al. [37] was consulted.
The number of immunostained cell bodies appearing in
each section from each person was counted; a high density
of NK-ir perikarya was considered when we found more
than 20 cell bodies/section; a moderate density when we
found 10–20 cell bodies/section, and a low density when
we found fewer than 10 cell bodies/section. The density of
the immunopositive fibers was graded under microscopic
observation into four categories: high, moderate, low and
single. This was accomplished by viewing the sections un-
der bright-field illumination at a constant magnification
with reference to photographs of defined series of densi-
ties [38].
Finally, photomicrographs were obtained with a Cool-
SNAP digital camera attached to a Zeiss Axiophot micro-
scope. To improve the visualization of the results, only the
brightness and contrast of the images were adjusted with-
out any further manipulation of the photographs.
Abbreviations used in figures
- 1: Caudal end of the motor hypoglossal nucleus
- 2: Caudal end of the dorsal motor nucleus of the vagus
- 4: Area postrema
- AbdNr: Abducens nerve
- AbdNu: Abducens nucleus
- AccNu: The nucleus of the accessory nerve
- ACSp: Anterior corticospinal tract
Figure 11
A. Immunoreactive fibers (arrows) containing neurokinin B in 
the periaqueductal gray (PAG). Compare this Figure with Fig-
ure 10A. Note a very low density of immunoreactive fibers 
containing neurokinin B in the PAG. No immunoreactive cell 
body containing neurokinin B was found in the PAG. D: dor-
sal; M: medial. Scale bar: 100 µm B. A few immunoreactive 
fibers (arrows) containing neurokinin B in the bulbar reticu-
lar formation (RetF) and in the dorsal accessory olivary 
nucleus (DAO). Compare this Figure with Figure 6B. Note a 
very low density of immunoreactive fibers containing neuro-
kinin B in the RetF and DAO. No immunoreactive cell body 
containing neurokinin B was observed in the RetF. D: dorsal; 
M: medial. Scale bar: 100 µmBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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- ALS: Anterolateral system
- AMV: Anterior medullary velum
- ArNu: Arcuate nucleus
- CA: Cerebral aqueduct
- CC: Crus cerebri
- CeGy: Medullary or tegmental central gray
- CoBul: Corticobulbar fibers
- CortNig: Corticonigral fibers
- CSNu: Principal trigeminal nucleus
- CSp: Corticospinal fibers
- CTT: Central tegmental tract
- D: Dorsal
- DAO: Dorsal accessory olivary nucleus
- DtegDec: Dorsal tegmental decussation
- DLF: Dorsal part of the medial longitudinal fascicle
- DMNu: Dorsal motor nucleus of the vagus
- DSCT: Dorsal spinocerebellar tract
- DTTr: Dorsal trigeminothalamic tract
- EAF: External arcuate fibers
- Fac, G: Facial nerve, internal genu
- FacNr: Facial nerve
- FacNu: Motor facial nucleus
- Fcu: Fasciculus cuneatus
- FGr: Fasciculus gracilis
- Fpon: Frontopontine fibers
- g: Gelatinosa
- HyNu: Motor hypoglossal nucleus
- IAF: Internal arcuate fibers
- IC, Br: Inferior colliculus, brachium
- IC, CNu: Inferior colliculus, central nucleus
- IC, Com: Inferior colliculus, commissure
- IC, LZ: Inferior colliculus, lateral zone
- ICP: Inferior cerebellar peduncle
- IPFo: Interpeduncular fossa
- IPNu: Interpeduncular nucleus
- JRB: Juxtarestiform body
- LCNu: Lateral cuneate nucleus
- LL: Lateral lemniscus
- LL, Nu: Nuclei of the lateral lemniscus (dorsal, ventral)
- LoCer: Locus ceruleus
- LRNu: Lateral reticular nucleus
- M: Medial
- m: Magnocellular
- MAO: Medial accessory olivary nucleus
- MCP: Middle cerebellar peduncle
- MesNu: Mesencephalic trigeminal nucleus
- MGB: Medial geniculate body
- MesTr: Mesencephalic tract of the trigeminal nerve
- ML: Medial lemniscus
- MLF: Medial longitudinal fascicle
- MVN: Medial vestibular nucleus
- NigSt: Nigrostriatal fibers
- NuAm: Nucleus ambiguus
- NuCu: Cuneate nucleus
- NuGr: Gracile nucleus
- NuPp: Nucleus prepositus hypoglossiBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/3
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- OcbF: Olivocerebellar fibers
- OcNr: Oculomotor nerve
- OcNu: Oculomotor nucleus
- Opon: Occipitopontine fibers
- PAG: Periaqueductal gray
- PalNig: Pallidonigral fibers
- PCbF: Pontocerebellar fibers
- PO: Principal part of the inferior olivary nucleus
- PonNu: Pontine nuclei
- Ppon: Parietopontine fibers
- Py: Pyramidal tract
- RB: Restiform body
- RetF: Reticular formation
- RetSp: Reticulospinal tract
- RNu: Red nucleus
- RuSp: Rubrospinal tract
- SC: Superior colliculus
- SCP: Superior cerebellar peduncle
- SCP, Dec: Superior cerebellar peduncle, decussation
- SN: Substantia nigra
- SO: Superior olive
- SolNu: Nucleus of the solitary tract
- SolTr: Solitary tract
- SpTec: Spinotectal tract
- SpTh: Spinothalamic tract
- SpTNu: Spinal trigeminal nucleus
- SpTT: Spinal trigeminal tract
- SpVN: Spinal (inferior) vestibular nucleus
- SSNu: Superior salivatory nucleus
- SVN: Superior vestibular nucleus
- TecSP: Tectospinal tract
- Tpon: Temporopontine fibers
- TrapB: Trapezoid body
- TrapNu: Trapezoid nucleus
- TriMoNu: Trigeminal motor nucleus (caudal part)
- TriNr: Trigeminal nerve
- TroNr: Trochlear nerve
- V: Ventricle
- VesSp: Vestibulospinal tract
- VSCT: Ventral spinocerebellar tract
- VTegDec: Ventral tegmental decussations
- VTTr: Ventral trigeminothalamic tract
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